Flu Vaccine for Secondary Prevention of Coronary Events

Published Online: Tuesday, March 22, 2011
Follow Pharmacy_Times:
This video presentation discusses the results of a new study that provides further evidence that influenza vaccine reduces major cardiovascular events in patients hospitalized for acute coronary syndrome.

Click here to access this third-party resource.
Related Articles
Aaron Steffenhagen, PharmD, BCPS, a clinical pharmacy manager at the University of Wisconsin Hospital, discusses what areas pharmacists should focus on during acute stroke codes.
Aaron Steffenhagen, PharmD, BCPS, a clinical pharmacy manager at the University of Wisconsin Hospital, discusses a pharmacist's door-to-door discharge role when managing an ischemic stroke patient.
Aaron Steffenhagen, PharmD, BCPS, a clinical pharmacy manager at the University of Wisconsin Hospital, discusses how pharmacists can enhance stroke care.
Patients turn to garlic supplements for a number of conditions, one of the most popular being the common cold. The basis for such action is the supposed antimicrobial and antiviral properties of the medicinal plant.
Latest Issues
$auto_registration$